{"gene":"TFAM","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2003,"finding":"Human mtDNA is packaged with TFAM: TFAM and mtDNA co-immunoprecipitate using anti-TFAM antibodies from human placental mitochondria, TFAM is released by DNase I digestion, and TFAM is abundant enough to coat the entire mtDNA molecule, demonstrating tight physical association of TFAM with mtDNA in vivo.","method":"Co-immunoprecipitation, subcellular fractionation, DNase I digestion assay","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with functional DNase I validation, foundational paper","pmids":["12626705"],"is_preprint":false},{"year":2011,"finding":"X-ray crystal structure of human TFAM bound to mitochondrial LSP promoter DNA reveals that TFAM forces DNA to undergo a U-turn, with each HMG-box domain wedging into the DNA minor groove to generate two kinks on one face, and a positively charged α-helix on the opposite face serving as a bending platform.","method":"X-ray crystallography with functional mutagenesis","journal":"Nature Structural & Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mechanistic validation of DNA bending","pmids":["22037171"],"is_preprint":false},{"year":2014,"finding":"Crystal structures of TFAM bound to HSP1 and non-specific DNA show TFAM imposes a U-turn in both contexts but binds HSP1 in the opposite orientation from LSP, explaining promoter-specific transcriptional requirements. TFAM dimerizes when DNA-bound; dimerization is dispensable for DNA bending and transcriptional activation but important for DNA compaction and looping.","method":"X-ray crystallography, in vitro transcription assay, dimerization mutagenesis","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1 — multiple crystal structures with mutagenesis and functional assays in one study","pmids":["24435062"],"is_preprint":false},{"year":2015,"finding":"Superresolution and electron microscopy showed that the mitochondrial nucleoid contains a single copy of mtDNA, and rotary-shadowing EM revealed that nucleoid formation in vitro is initiated by TFAM aggregation and cross-strand binding, establishing the fundamental organizational unit of the nucleoid.","method":"Superresolution microscopy (STED), electron cryo-tomography, rotary shadowing EM, biochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal structural/imaging methods with in vitro reconstitution","pmids":["26305956"],"is_preprint":false},{"year":2010,"finding":"Reconstituted in vitro transcription demonstrates that only TFAM and TFB2M (not TFB1M) are required to drive transcription from LSP and HSP1, acting synergistically to increase transcription 100–200-fold over RNA polymerase alone, with maximal activity when TFAM is equimolar to the DNA template.","method":"Reconstituted in vitro transcription with recombinant proteins","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — fully reconstituted in vitro system with systematic factor omission","pmids":["20410300"],"is_preprint":false},{"year":2016,"finding":"2-aminopurine fluorescence mapping of promoter melting shows TFAM has post-recruitment roles in LSP promoter melting and stabilization of the open complex; POLRMT requires both TFB2M and TFAM to efficiently melt the promoter, and TFAM is necessary for synthesis of abortive RNAs longer than 2-mer.","method":"2-aminopurine fluorescence assay, equilibrium binding assay, abortive RNA synthesis assay","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 — multiple in vitro biochemical methods in a single study reconstituting transcription initiation steps","pmids":["27903899"],"is_preprint":false},{"year":2012,"finding":"TFAM is phosphorylated within HMG box 1 (HMG1) by cAMP-dependent protein kinase inside mitochondria; HMG1 phosphorylation impairs TFAM DNA binding and transcriptional activation. Only DNA-free TFAM is degraded by the Lon protease; in cells with normal mtDNA levels, phosphorylated TFAM is selectively degraded by Lon.","method":"Mass spectrometry phosphorylation mapping, in vitro kinase assay, in vitro transcription, Lon protease degradation assay, siRNA knockdown","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay, in vitro transcription, and protease assay with mutagenesis, replicated across cell conditions","pmids":["23201127"],"is_preprint":false},{"year":2014,"finding":"ERK1/2 directly phosphorylates TFAM at serine 177; phosphomimetic mutation at S177 recapitulates the effect of MPP+ in decreasing TFAM binding to the LSP and suppressing mitochondrial transcription, and mutant TFAM fails to rescue respiratory function.","method":"Mass spectrometry phosphosite identification, site-directed mutagenesis, TFAM-DNA binding assay, mitochondrial transcription assay","journal":"Mitochondrion","confidence":"High","confidence_rationale":"Tier 1 — MS identification combined with mutagenesis and functional transcription/binding assays","pmids":["24768991"],"is_preprint":false},{"year":2018,"finding":"TFAM is lysine-acetylated within HMG box 1; acetyl-lysine and phosphoserine mimics both reduce TFAM DNA compaction capacity but through distinct kinetic mechanisms: the acetyl-lysine mimic shows a lower on-rate, whereas the phosphoserine mimic shows both decreased on-rate and increased off-rate with faster diffusion of TFAM along DNA.","method":"Single-molecule fluorescence assay, bulk binding assay, site-directed mutagenesis with PTM mimics","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 — single-molecule and ensemble methods with mutagenesis in one study","pmids":["29897602"],"is_preprint":false},{"year":2021,"finding":"The TFAM-to-mtDNA ratio (not absolute TFAM level) determines mtDNA expression; very high TFAM levels in mouse skeletal muscle repress mtDNA transcription, while in liver elevated LONP1 protease and mtRNA polymerase counteract TFAM-mediated silencing, establishing TFAM as a general repressor of mtDNA expression.","method":"Transgenic mouse overexpression, tissue-specific analysis, OXPHOS functional assays","journal":"Life Science Alliance","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with tissue-specific mechanistic dissection","pmids":["34462320"],"is_preprint":false},{"year":2013,"finding":"ChIP-seq in human cells demonstrates that TFAM uniformly coats the entire mitochondrial genome without preferred binding sites (beyond promoter regions) and shows no robust binding to the nuclear genome, establishing genome-wide non-specific mtDNA packaging by TFAM.","method":"ChIP-seq","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 2 — genome-wide direct binding assay in human cells","pmids":["23991223"],"is_preprint":false},{"year":2009,"finding":"PDX1 directly regulates TFAM as a transcriptional target in beta cells; adenoviral overexpression of TFAM in PDX1-dominant-negative islets rescues mtDNA copy number, respiratory chain activity, ATP synthesis, and glucose-stimulated insulin secretion.","method":"Transcript profiling, promoter binding assay, adenoviral overexpression, respiratory chain activity assay, insulin secretion assay","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 2 — direct promoter occupancy and functional rescue with multiple orthogonal readouts","pmids":["19656489"],"is_preprint":false},{"year":2024,"finding":"TFAM acts as an autophagy receptor (nucleoid-phagy) for cytoplasmic mtDNA via a LIR (LC3-interacting region) motif that enables direct binding to LC3 on autolysosomes; mutating the LIR motif increases cytoplasmic mtDNA accumulation and activates inflammatory signaling without affecting TFAM's mitochondrial functions.","method":"LIR motif mutagenesis, co-immunoprecipitation with LC3, live-cell autolysosome imaging, inflammatory pathway readout","journal":"Nature Cell Biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of functional motif with mechanistic imaging and signaling readout in one study","pmids":["38783142"],"is_preprint":false},{"year":2022,"finding":"TFAM deficiency blocks the TCA cycle and increases intracellular malonyl-CoA, leading to malonylation of the actin nucleator mDia2, which promotes mDia2 nuclear translocation and polymerization of nuclear actin, thereby altering chromatin accessibility and upregulating metastasis-associated gene programs in liver cancer.","method":"Metabolomics, malonylation proteomics, nuclear actin imaging, chromatin accessibility assay, in vivo metastasis model","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing a novel retrograde signaling pathway","pmids":["35451091"],"is_preprint":false},{"year":2010,"finding":"TFAM and TFB2M localize to the nucleus in rat neonatal cardiomyocytes and directly bind the Serca2 gene promoter (at −122 to −114 nt and −122 to −117 nt regions respectively) as shown by ChIP and fluorescence correlation spectroscopy; mutation of these sites decreases Serca2 transcription.","method":"Chromatin immunoprecipitation (ChIP), fluorescence correlation spectroscopy, promoter mutation/reporter assay, immunostaining","journal":"Cardiovascular Research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and FCS in a single lab, nuclear localization confirmed but nuclear role is non-canonical","pmids":["21113058"],"is_preprint":false},{"year":2014,"finding":"Nuclear TFAM suppresses its own gene expression by interacting with NRF-1 and acting as an NRF-1 repressor; TFAM co-immunoprecipitates with NRF-1, and mitochondria targeting sequence-deficient TFAM represses the Tfam promoter to the same degree, indicating this autoregulatory role is nuclear and independent of mitochondrial function.","method":"Immunostaining, subcellular fractionation, GFP fusion localization, co-immunoprecipitation, luciferase promoter assay","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP and reporter assay in a single lab; nuclear role is non-canonical but mechanistically supported","pmids":["24875355"],"is_preprint":false},{"year":2015,"finding":"H2S (via the CSE/H2S system) maintains TFAM expression and mtDNA copy number by S-sulfhydrating the transcriptional repressor IRF-1, enhancing its binding to the Dnmt3a promoter and reducing Dnmt3a expression, thereby preventing TFAM promoter methylation.","method":"S-sulfhydration assay, ChIP, bisulfite sequencing/methylation assay, siRNA knockdown, qPCR","journal":"Antioxidants & Redox Signaling","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods in single lab linking H2S to TFAM epigenetic regulation","pmids":["25758951"],"is_preprint":false},{"year":2018,"finding":"In kidney fibrosis, Notch2 signaling (activated by Jagged1) directly represses Tfam transcription as identified by chromatin immunoprecipitation; re-expression of Tfam in tubule cells prevents Notch-induced metabolic and profibrotic reprogramming, and tubule-specific Tfam deletion itself causes fibrosis.","method":"Chromatin immunoprecipitation (ChIP), genome-wide expression profiling, conditional knockout mice, adenoviral re-expression","journal":"PLoS Biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus in vivo genetic epistasis with rescue experiment","pmids":["30226866"],"is_preprint":false},{"year":2021,"finding":"mtROS promotes Lon protease-mediated TFAM degradation and suppresses TFAM transcription, reducing mtDNA copy number; silencing TFAM abolishes the rescue of mitochondrial function and cytokine release by the mtROS inhibitor Mito-Tempo, placing TFAM downstream of mtROS in kidney injury.","method":"Lon protease functional assay, TFAM knockdown (siRNA), mitochondrial respiration assay, cytokine measurement, Mito-Tempo pharmacological inhibition","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via TFAM silencing with multiple functional readouts in one lab","pmids":["33408785"],"is_preprint":false},{"year":2020,"finding":"In sepsis, ATF4 represses TFAM by binding to and inhibiting the transcriptional activity of NRF1 (a key TFAM activator) at its promoter; hepatocyte-specific TFAM overexpression rescues alcohol-induced mitochondrial dysfunction and liver damage in mice.","method":"ATF4 knockout mice, TFAM overexpression mice, promoter binding assay (ChIP/luciferase), mitochondrial biogenesis/respiration assays","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic models combined with direct promoter binding, replicated in cells and mice","pmids":["33177163"],"is_preprint":false},{"year":2022,"finding":"GCN5L1 acetyltransferase acetylates TFAM at lysine 76 (K76), which inhibits TFAM binding to the mitochondrial import receptor TOM70, thereby reducing TFAM import into mitochondria and mitochondrial biogenesis in acute kidney injury.","method":"Acetylated proteomics, proximity ligation assay, co-immunoprecipitation, GCN5L1 knockdown, mtDNA copy number assay","journal":"Journal of Translational Medicine","confidence":"High","confidence_rationale":"Tier 1-2 — acetylome proteomics identifying specific site, confirmed by PLA and co-IP with functional import assay","pmids":["36474281"],"is_preprint":false},{"year":2023,"finding":"SIRT3 deacetylates TFAM at K5, K7, and K8 residues as demonstrated by immunoprecipitation and mass spectrometry; decreased SIRT3 leads to hyper-acetylated TFAM, impaired mitochondrial function, and vascular dementia pathology.","method":"Co-immunoprecipitation, mass spectrometry, SIRT3 inhibitor/knockdown, mitochondrial function assays","journal":"Phytomedicine","confidence":"Medium","confidence_rationale":"Tier 2 — IP-MS identifying specific acetylation sites with functional correlates in single lab","pmids":["38547618"],"is_preprint":false},{"year":2014,"finding":"Extracellular TFAM acts as a DAMP recognized by human microglia: recombinant human TFAM induces secretion of IL-1β, IL-6, and IL-8 from THP-1 monocytic cells and, with IFN-γ, elicits cytotoxic secretions from microglia and monocytes through a mechanism partially dependent on JNK activation.","method":"Recombinant protein treatment of primary human microglia and THP-1 cells, cytokine ELISA, neurotoxicity assay, specific kinase inhibitors","journal":"Molecular and Cellular Neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — recombinant protein functional assay in multiple human cell types with inhibitor validation","pmids":["24769106"],"is_preprint":false},{"year":2018,"finding":"Release of TFAM from apoptotic cancer cells acts as a mitochondrial DAMP that contributes to immunogenic cell death via the receptor AGER; neutralizing antibodies to TFAM or AGER abolish the immunogenic effect of spautin-1-treated cancer cells in vivo.","method":"Neutralizing antibody blockade, in vivo tumor inoculation, in vitro apoptosis assay","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-specific antibody blockade in vivo with functional readout","pmids":["29872558"],"is_preprint":false},{"year":2022,"finding":"Crystal structure of TFAM bound to non-sequence-specific DNA containing a GN10G motif reveals that TFAM bridges two DNA substrates via two guanine-specific interactions; mutagenesis and biochemical assays show the GN10G consensus is essential for transcription initiation and contributes to general DNA binding.","method":"X-ray crystallography, site-directed mutagenesis, in vitro transcription assay, DNA binding assay","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and functional assays","pmids":["34928349"],"is_preprint":false},{"year":2023,"finding":"TFAM forms DNA-protein cross-links (DPCs) with abasic (AP) sites in mtDNA: TFAM cleaves AP-DNA, generating a 3'-phospho-α,β-unsaturated aldehyde (3'pUA) that reacts with Cys residues of TFAM to form stable DPCs, with Lys residues critical for initial AP-DNA cleavage; glutathione competes with TFAM-DPC formation.","method":"In vitro DPC formation assay, mass spectrometry, mutagenesis of Lys/Cys residues, cellular DPC assay with glutathione modulation","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 — in vitro and cellulo mechanistic assays with mutagenesis identifying reactive residues","pmids":["36583367"],"is_preprint":false},{"year":2001,"finding":"During mammalian spermatogenesis, mitochondrial TFAM protein levels are progressively downregulated coincident with downregulation of mtDNA copy number, establishing a direct in vivo correlation between mitochondrial TFAM abundance and mtDNA copy number control during differentiation.","method":"Immunoblotting with subcellular fractionation, mtDNA quantification across spermatogenic stages in rat, mouse, and human","journal":"Mammalian Genome","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein measurement across developmental stages, conserved across three mammalian species","pmids":["11668394"],"is_preprint":false},{"year":2022,"finding":"TFAM-deficient alveolar macrophages (AMs) show diminished proliferation/self-renewal gene programs and increased inflammatory gene expression; conditional TFAM knockout in mice reduces AM numbers and impairs AM maturation without affecting AM precursor generation or initial differentiation, establishing TFAM-mediated mitochondrial metabolism as specifically required for AM compartment maintenance.","method":"Conditional knockout mice, transcriptional profiling, flow cytometry, in vivo influenza infection model","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific in vivo genetic knockout with transcriptomics and functional immune readouts","pmids":["35165165"],"is_preprint":false},{"year":2023,"finding":"TFAM deficiency in dendritic cells causes mitochondrial dysfunction and cytosolic mtDNA leakage that activates the cGAS-STING pathway, enhancing antigen presentation and reversing immunosuppressive tumor microenvironment; STING inhibitors abrogate this effect, placing TFAM upstream of cGAS-STING in DC immune activation.","method":"Conditional knockout mice, primary BMDC functional assays, STING inhibitor, tumor models, antigen presentation assay","journal":"Journal for Immunotherapy of Cancer","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with pharmacological epistasis and in vivo tumor model","pmids":["36858460"],"is_preprint":false},{"year":2018,"finding":"KLF16 transcription factor directly suppresses glioma cell proliferation by binding a site near the TFAM transcription start site and repressing TFAM expression, as validated by luciferase assay and chromatin immunoprecipitation.","method":"Luciferase reporter assay, chromatin immunoprecipitation (ChIP), KLF16 overexpression/siRNA, in vivo xenograft","journal":"Artificial Cells, Nanomedicine, and Biotechnology","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP and reporter assay in single lab for transcriptional regulation","pmids":["29374989"],"is_preprint":false},{"year":2007,"finding":"The transcription factor hStaf/ZNF143 is required for normal human TFAM gene expression: two conserved hStaf/ZNF143 binding sites in the TFAM promoter are identified by promoter binding assays and ChIP, and mutation of these sites reduces TFAM promoter activity.","method":"Promoter binding assay, transient transfection with mutant reporter constructs, chromatin immunoprecipitation (ChIP)","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and promoter mutagenesis in a single lab","pmids":["17707600"],"is_preprint":false},{"year":2022,"finding":"Genetic analysis using chimeric TFAM variants (GeneSwap approach) shows that TFAM's contributions to mtDNA replication and respiratory chain biogenesis are genetically separable: variant Ch13 has low mtDNA copy number but robust respiration, while Ch22 has the converse; residues making DNA contacts are primarily responsible for mtDNA replication.","method":"Chimeric protein engineering (GeneSwap), mtDNA copy number assay, respiratory function assay, mutagenesis","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1-2 — structure-guided mutagenesis with two complementary functional readouts, single lab","pmids":["36497015"],"is_preprint":false},{"year":2023,"finding":"GCN5L1 loss reduces TFAM acetylation, which is linked to decreased mtDNA levels and impaired mitochondrial bioenergetics under hemodynamic stress in the heart; GCN5L1 cardiomyocyte-specific knockout mice show exacerbated heart failure after transaortic constriction.","method":"Cardiomyocyte-specific GCN5L1 knockout mice, TAC model, TFAM acetylation assay, mtDNA quantification, bioenergetics assay","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo conditional knockout with acetylation assay and functional mitochondrial readouts","pmids":["37305705"],"is_preprint":false},{"year":2020,"finding":"TFAM knockdown in gastric cancer cells activates mtDNA depletion-dependent calcium-mediated retrograde signaling through the CFAP65-PCK1 axis; knockdown of CFAP65 or PCK1 rescues cell morphology and proliferation changes caused by TFAM depletion, and mtDNA depletion by ddC is sufficient to induce CFAP65 and PCK1 upregulation.","method":"TFAM siRNA knockdown, mtDNA depletion by ddC, gene-specific knockdown rescue, transcriptomic analysis","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via rescue experiment placing CFAP65-PCK1 downstream of TFAM-mtDNA in retrograde signaling","pmids":["29259235"],"is_preprint":false},{"year":2023,"finding":"SIRT3 deacetylates TFAM, and sepsis-induced AKI is associated with melatonin promoting SIRT3-mediated TFAM deacetylation to promote mitophagy.","method":"In vivo sepsis model, SIRT3 activity assay, mitophagy assay (mKeima), TFAM acetylation measurement","journal":"Autophagy","confidence":"Low","confidence_rationale":"Tier 3 — abstract does not report direct mechanistic deacetylation assay details for TFAM","pmids":["37651673"],"is_preprint":false},{"year":2018,"finding":"RNA-binding protein HuR binds and stabilizes TFAM mRNA in irradiated cancer cells; radiation-activated ATM/p38 signaling promotes nuclear-to-cytosol translocation of HuR, enhancing its binding to TFAM mRNA without affecting TFAM transcription or mRNA intrinsic stability.","method":"RNA immunoprecipitation (RIP), HuR knockdown, subcellular fractionation of HuR, ATM/p38 inhibitors, mRNA stability assay","journal":"Cancer Science","confidence":"Medium","confidence_rationale":"Tier 2 — RIP demonstrating direct HuR-TFAM mRNA interaction with pathway inhibitor validation","pmids":["29856906"],"is_preprint":false},{"year":2011,"finding":"ERAL1 (an ERA-like G-protein) and p32 are identified as TFAM-associated proteins within the mitochondrial nucleoid involved in RNA metabolism: ERAL1 binds mitochondrial 12S rRNA and is an important constituent of the mitochondrial small ribosomal subunit.","method":"Co-immunoprecipitation/pulldown to identify TFAM interactors, rRNA binding assay","journal":"Biochimica et Biophysica Acta","confidence":"Low","confidence_rationale":"Tier 3 — pulldown-based identification of interactors, limited functional follow-up for TFAM itself","pmids":["21920408"],"is_preprint":false},{"year":2018,"finding":"TFAM loss in intestinal epithelium (Shh-Cre conditional knockout) impairs villus elongation and enterocyte maturation during fetal development, and in adult intestinal epithelium reduces stem cell renewal and organoid formation while preserving transit-amplifying zone proliferation.","method":"Conditional knockout mice (Shh-Cre and inducible adult deletion), molecular profiling, intestinal organoid formation assay","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific genetic knockout with distinct stage-specific phenotypic readouts and organoid assay","pmids":["29684311"],"is_preprint":false},{"year":2021,"finding":"Conditional Tfam ablation in adult mouse cardiomyocytes reveals functional resilience: mtDNA content, mitochondrial function, and cardiac function are preserved despite decreased transcript abundance during the acute phase, whereas long-term inactivation downregulates the core mtDNA transcription/replication machinery and causes cardiomyopathy.","method":"Conditional knockout mice, mtDNA quantification, mitochondrial function assays, cardiac function assays over time","journal":"American Journal of Physiology - Cell Physiology","confidence":"High","confidence_rationale":"Tier 2 — conditional in vivo genetic model with longitudinal functional analysis","pmids":["33760663"],"is_preprint":false}],"current_model":"TFAM is a dual-function HMG-box protein that (1) activates mitochondrial transcription initiation by bending promoter DNA into a U-turn and working synergistically with TFB2M and POLRMT to melt the promoter, and (2) packages the entire mitochondrial genome into single-copy nucleoids through cross-strand binding and dimerization; its activity is fine-tuned by cAMP-dependent protein kinase (HMG1 phosphorylation at S177 via ERK, or PKA) and acetyltransferase GCN5L1 (K76) / deacetylase SIRT3 (K5/7/8), with phosphorylated/acetylated DNA-free TFAM selectively degraded by the Lon protease, while cytoplasmic mtDNA released upon TFAM loss activates cGAS-STING inflammatory signaling that TFAM itself limits by acting as an autophagy receptor for nucleoid-phagy via its LIR motif."},"narrative":{"teleology":[{"year":2001,"claim":"An in vivo correlation between TFAM protein abundance and mtDNA copy number was established across mammalian spermatogenesis, raising the question of whether TFAM directly maintains mtDNA levels.","evidence":"Immunoblotting and mtDNA quantification across spermatogenic stages in rat, mouse, and human","pmids":["11668394"],"confidence":"Medium","gaps":["Correlative; no genetic manipulation to test causality","Mechanism of TFAM downregulation during spermatogenesis unknown"]},{"year":2003,"claim":"The physical association of TFAM with mtDNA in vivo was demonstrated, establishing that TFAM is an abundant nucleoid component rather than merely a transient transcription factor.","evidence":"Co-immunoprecipitation from human placental mitochondria with DNase I release validation","pmids":["12626705"],"confidence":"High","gaps":["Stoichiometry was estimated but not precisely determined","Whether TFAM binding is uniform or site-specific was unknown"]},{"year":2010,"claim":"Reconstitution of minimal mitochondrial transcription demonstrated that TFAM and TFB2M (but not TFB1M) are the essential co-activators of POLRMT, defining the core transcription initiation machinery.","evidence":"Fully reconstituted in vitro transcription with systematic factor omission","pmids":["20410300"],"confidence":"High","gaps":["How TFAM mechanistically contributes beyond recruitment was not resolved","Structural basis of promoter recognition was still unknown"]},{"year":2011,"claim":"The crystal structure of TFAM on LSP revealed that TFAM bends promoter DNA into a U-turn through two HMG-box insertions, providing the first atomic-resolution mechanism for how TFAM remodels DNA for transcription.","evidence":"X-ray crystallography of human TFAM–LSP complex with functional mutagenesis","pmids":["22037171"],"confidence":"High","gaps":["Structure on HSP1 and non-specific DNA was not yet available","Role of DNA bending in compaction versus transcription was unresolved"]},{"year":2012,"claim":"Discovery that cAMP-dependent kinase phosphorylates TFAM within HMG1, impairing DNA binding and rendering TFAM susceptible to Lon protease degradation, established the first post-translational mechanism coupling signaling to mtDNA copy-number control.","evidence":"Mass spectrometry phosphomapping, in vitro kinase and Lon degradation assays, siRNA knockdown","pmids":["23201127"],"confidence":"High","gaps":["In vivo kinase identity in mitochondria was debated","Whether acetylation similarly regulated Lon degradation was unknown"]},{"year":2013,"claim":"ChIP-seq revealed that TFAM uniformly coats the entire mitochondrial genome without preferred non-promoter binding sites, confirming its role as a general mtDNA packaging factor.","evidence":"Genome-wide ChIP-seq in human cells","pmids":["23991223"],"confidence":"High","gaps":["Resolution limited by nucleoid compaction","Whether coating density varies with physiological state was untested"]},{"year":2014,"claim":"Crystal structures of TFAM on HSP1 and non-specific DNA showed that TFAM imposes a U-turn regardless of sequence but binds the two promoters in opposite orientations; dimerization was shown to be required for DNA compaction but dispensable for transcription activation, separating the two functions structurally.","evidence":"X-ray crystallography, in vitro transcription, dimerization mutagenesis","pmids":["24435062"],"confidence":"High","gaps":["How dimerization leads to higher-order compaction at the nucleoid scale was not resolved","In vivo validation of dimerization mutants was lacking"]},{"year":2014,"claim":"ERK1/2 was identified as a second kinase phosphorylating TFAM at S177, linking mitochondrial toxin (MPP+) signaling to reduced TFAM–DNA binding and transcriptional suppression.","evidence":"Mass spectrometry, phosphomimetic mutagenesis, TFAM-DNA binding and transcription assays","pmids":["24768991"],"confidence":"High","gaps":["How ERK1/2 accesses mitochondrial TFAM was not fully established","Interplay between PKA and ERK phosphorylation sites was not studied"]},{"year":2015,"claim":"Super-resolution and electron microscopy established that each nucleoid contains a single mtDNA copy, and TFAM cross-strand binding and aggregation initiate nucleoid compaction, defining the fundamental unit of mtDNA organization.","evidence":"STED microscopy, cryo-ET, rotary shadowing EM, in vitro reconstitution","pmids":["26305956"],"confidence":"High","gaps":["Full 3D architecture of the nucleoid in situ was not achieved","Contribution of other nucleoid proteins to compaction was not addressed"]},{"year":2016,"claim":"Fluorescence-based promoter melting assays revealed that TFAM has post-recruitment roles in open complex formation, working with TFB2M to melt LSP DNA and enable productive RNA synthesis beyond 2-mer abortive transcripts.","evidence":"2-aminopurine fluorescence, equilibrium binding, and abortive RNA synthesis assays","pmids":["27903899"],"confidence":"High","gaps":["Structural intermediates of the open complex were not visualized","Whether TFAM participates in promoter escape was unknown"]},{"year":2018,"claim":"Single-molecule studies demonstrated that acetylation and phosphorylation of TFAM reduce DNA compaction through kinetically distinct mechanisms—acetylation lowering the on-rate and phosphorylation increasing the off-rate—explaining how different modifications yield different functional outcomes.","evidence":"Single-molecule fluorescence, bulk binding, PTM-mimic mutagenesis","pmids":["29897602"],"confidence":"High","gaps":["Physiological acetylation sites responsible were not mapped in this study","Combined effects of multiple simultaneous PTMs were not tested"]},{"year":2018,"claim":"Tissue-specific conditional knockout of TFAM in kidney tubules caused fibrosis, and Notch2 was shown to directly repress Tfam transcription, establishing TFAM as a downstream effector whose loss mediates Notch-driven metabolic reprogramming.","evidence":"ChIP for Notch2 on Tfam promoter, conditional Tfam knockout mice, adenoviral Tfam rescue","pmids":["30226866"],"confidence":"High","gaps":["Whether other developmental pathways similarly regulate Tfam transcription was untested","Mechanism linking TFAM loss to profibrotic gene programs was incompletely defined"]},{"year":2021,"claim":"In vivo TFAM overexpression in mice demonstrated that the TFAM-to-mtDNA ratio—not absolute TFAM level—determines transcriptional output, with excess TFAM silencing mtDNA expression in skeletal muscle, resolving a long-standing paradox about TFAM's dual activator/repressor behavior.","evidence":"Transgenic TFAM-overexpressing mice with tissue-specific OXPHOS and transcription analysis","pmids":["34462320"],"confidence":"High","gaps":["How cells sense and regulate the ratio was not determined","Whether the ratio model applies to all tissues equally was not fully tested"]},{"year":2022,"claim":"GCN5L1 was identified as the acetyltransferase that acetylates TFAM at K76, inhibiting its binding to the TOM70 import receptor and thereby reducing mitochondrial TFAM import, revealing a new layer of TFAM regulation at the protein import step.","evidence":"Acetylome proteomics, proximity ligation assay, co-IP, GCN5L1 knockdown with mtDNA readout","pmids":["36474281"],"confidence":"High","gaps":["Whether K76 acetylation also affects DNA binding inside mitochondria was not tested","In vivo GCN5L1–TFAM epistasis was limited to kidney injury context"]},{"year":2022,"claim":"A crystal structure of TFAM on non-specific DNA revealed a GN10G guanine-specific recognition motif that bridges two DNA substrates, explaining how TFAM achieves both sequence-specific promoter recognition and genome-wide non-specific packaging.","evidence":"X-ray crystallography, site-directed mutagenesis, in vitro transcription and binding assays","pmids":["34928349"],"confidence":"High","gaps":["Contribution of GN10G to nucleoid architecture in vivo was not tested","Whether GN10G frequency in mtDNA influences regional compaction is unknown"]},{"year":2022,"claim":"Chimeric TFAM variants demonstrated that TFAM's contributions to mtDNA replication and respiratory chain biogenesis are genetically separable, with DNA-contacting residues primarily driving replication.","evidence":"GeneSwap chimeric protein engineering with mtDNA copy number and respiration assays","pmids":["36497015"],"confidence":"Medium","gaps":["Structural basis for the separation of function was not determined","Only tested in cell culture, not in vivo"]},{"year":2023,"claim":"TFAM was shown to form covalent DNA-protein crosslinks at abasic sites via a lyase-like activity, with Lys residues cleaving AP-DNA to generate a reactive aldehyde trapped by Cys residues, establishing TFAM as a participant in mtDNA damage responses.","evidence":"In vitro DPC formation assay, mass spectrometry of crosslinked species, Lys/Cys mutagenesis, cellular DPC assay","pmids":["36583367"],"confidence":"High","gaps":["Biological consequence of TFAM-DPC accumulation for mtDNA maintenance is unknown","Whether DPCs are resolved by specific repair pathways was not addressed"]},{"year":2023,"claim":"SIRT3 was identified as the deacetylase acting on TFAM at K5, K7, and K8, placing TFAM acetylation under mitochondrial sirtuin control and linking SIRT3 decline to TFAM hyper-acetylation and mitochondrial dysfunction.","evidence":"IP-MS identifying acetylation sites, SIRT3 knockdown/inhibitor, mitochondrial function assays","pmids":["38547618"],"confidence":"Medium","gaps":["Direct in vitro deacetylation assay with purified SIRT3 on specific TFAM peptides was not shown","Interplay between GCN5L1 acetylation at K76 and SIRT3 deacetylation at N-terminal lysines was not studied"]},{"year":2023,"claim":"TFAM loss in dendritic cells was shown to trigger cytosolic mtDNA release and cGAS–STING activation, enhancing antigen presentation and anti-tumor immunity, establishing TFAM as a gatekeeper preventing innate immune activation by mitochondrial DNA.","evidence":"Conditional Tfam knockout in DCs, STING pharmacological inhibition, tumor models, antigen presentation assays","pmids":["36858460"],"confidence":"High","gaps":["Whether the effect is specific to dendritic cells or general to all antigen-presenting cells was not established","Direct visualization of mtDNA escape from mitochondria was limited"]},{"year":2024,"claim":"TFAM was discovered to function as an autophagy receptor for cytoplasmic mtDNA through a LIR motif that binds LC3, defining a nucleoid-phagy pathway that clears escaped mtDNA and suppresses cGAS–STING signaling independently of TFAM's intramitochondrial roles.","evidence":"LIR motif mutagenesis, co-IP with LC3, live-cell autolysosome imaging, inflammatory pathway readout","pmids":["38783142"],"confidence":"High","gaps":["Whether nucleoid-phagy operates in all cell types is unknown","Regulation of TFAM's LIR motif accessibility was not addressed","How cytoplasmic TFAM is distinguished from mitochondrial TFAM for this function is unclear"]},{"year":null,"claim":"Outstanding questions include: (1) the full 3D structure of the TFAM-organized nucleoid in situ; (2) how the combined landscape of phosphorylation, acetylation, and DPC formation is integrated to control TFAM's partition between transcription activation, genome packaging, and degradation; and (3) the structural and regulatory basis for TFAM's cytoplasmic autophagy receptor function versus its mitochondrial roles.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in situ structure of the complete nucleoid exists","Combinatorial PTM effects on TFAM have not been reconstituted","Mechanism governing TFAM cytoplasmic pool availability for nucleoid-phagy is undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,10,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,5]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[3,2,10]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[12]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,3,10,37,38]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,3,10]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[3,26,31]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28,22,23]}],"complexes":["mitochondrial nucleoid","mitochondrial transcription initiation complex (TFAM–TFB2M–POLRMT)"],"partners":["TFB2M","POLRMT","LONP1","GCN5L1","SIRT3","TOMM70","AGER","MAP1LC3B"],"other_free_text":[]},"mechanistic_narrative":"TFAM is a dual-function HMG-box protein that serves as both the principal architectural packager of the mitochondrial genome and an essential activator of mitochondrial transcription. Structurally, TFAM bends promoter DNA into a U-turn via two HMG-box domains that wedge into the minor groove, and it cooperates with TFB2M and POLRMT to melt the promoter and initiate transcription; at higher stoichiometries, TFAM coats the entire mtDNA through non-sequence-specific binding, cross-strand bridging, and dimerization to compact it into single-copy nucleoids, with the TFAM-to-mtDNA ratio determining whether expression is activated or repressed [PMID:22037171, PMID:24435062, PMID:20410300, PMID:26305956, PMID:34462320]. TFAM activity is fine-tuned by phosphorylation (cAMP-dependent kinase, ERK1/2 at S177) and acetylation (GCN5L1 at K76; SIRT3 at K5/K7/K8), which reduce DNA binding and compaction through distinct kinetic mechanisms; DNA-free phosphorylated or acetylated TFAM is selectively degraded by the Lon protease, coupling post-translational modification to mtDNA copy-number homeostasis [PMID:23201127, PMID:24768991, PMID:29897602, PMID:36474281, PMID:38547618]. Beyond its canonical mitochondrial roles, TFAM functions as an autophagy receptor for cytoplasmic mtDNA via a LIR motif that binds LC3, limiting cGAS–STING inflammatory signaling triggered by escaped mtDNA, and when released extracellularly acts as a DAMP recognized through the receptor AGER [PMID:38783142, PMID:36858460, PMID:29872558]."},"prefetch_data":{"uniprot":{"accession":"Q00059","full_name":"Transcription factor A, mitochondrial","aliases":["Mitochondrial transcription factor 1","MtTF1","Transcription factor 6","TCF-6","Transcription factor 6-like 2"],"length_aa":246,"mass_kda":29.1,"function":"Binds to the mitochondrial light strand promoter and functions in mitochondrial transcription regulation (PubMed:29445193, PubMed:32183942). Component of the mitochondrial transcription initiation complex, composed at least of TFB2M, TFAM and POLRMT that is required for basal transcription of mitochondrial DNA (PubMed:29149603). In this complex, TFAM recruits POLRMT to a specific promoter whereas TFB2M induces structural changes in POLRMT to enable promoter opening and trapping of the DNA non-template strand (PubMed:20410300). Required for accurate and efficient promoter recognition by the mitochondrial RNA polymerase (PubMed:22037172). Promotes transcription initiation from the HSP1 and the light strand promoter by binding immediately upstream of transcriptional start sites (PubMed:22037172). Is able to unwind DNA (PubMed:22037172). Bends the mitochondrial light strand promoter DNA into a U-turn shape via its HMG boxes (PubMed:1737790). Required for maintenance of normal levels of mitochondrial DNA (PubMed:19304746, PubMed:22841477). May play a role in organizing and compacting mitochondrial DNA (PubMed:22037171)","subcellular_location":"Mitochondrion; Mitochondrion matrix, mitochondrion nucleoid","url":"https://www.uniprot.org/uniprotkb/Q00059/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TFAM","classification":"Common Essential","n_dependent_lines":833,"n_total_lines":1208,"dependency_fraction":0.6895695364238411},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"PPM1G","stoichiometry":0.2},{"gene":"PTMA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TFAM","total_profiled":1310},"omim":[{"mim_id":"619518","title":"MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO","url":"https://www.omim.org/entry/619518"},{"mim_id":"618583","title":"MITOCHONDRIAL TRANSCRIPTION RESCUE FACTOR 1; MTRES1","url":"https://www.omim.org/entry/618583"},{"mim_id":"617698","title":"3-@METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9","url":"https://www.omim.org/entry/617698"},{"mim_id":"617462","title":"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1; PPRC1","url":"https://www.omim.org/entry/617462"},{"mim_id":"617156","title":"MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15","url":"https://www.omim.org/entry/617156"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TFAM"},"hgnc":{"alias_symbol":[],"prev_symbol":["TCF6","TCF6L2"]},"alphafold":{"accession":"Q00059","domains":[{"cath_id":"1.10.30.10","chopping":"41-120","consensus_level":"high","plddt":95.6037,"start":41,"end":120},{"cath_id":"1.10.30.10","chopping":"160-229","consensus_level":"high","plddt":97.057,"start":160,"end":229}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00059","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q00059-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q00059-F1-predicted_aligned_error_v6.png","plddt_mean":85.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TFAM","jax_strain_url":"https://www.jax.org/strain/search?query=TFAM"},"sequence":{"accession":"Q00059","fasta_url":"https://rest.uniprot.org/uniprotkb/Q00059.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q00059/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00059"}},"corpus_meta":[{"pmid":"33408785","id":"PMC_33408785","title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33408785","citation_count":618,"is_preprint":false},{"pmid":"17280879","id":"PMC_17280879","title":"Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions.","date":"2006","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/17280879","citation_count":367,"is_preprint":false},{"pmid":"12626705","id":"PMC_12626705","title":"Human mitochondrial DNA is packaged with TFAM.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12626705","citation_count":303,"is_preprint":false},{"pmid":"26305956","id":"PMC_26305956","title":"Cross-strand binding of TFAM to a single mtDNA molecule forms the mitochondrial nucleoid.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26305956","citation_count":283,"is_preprint":false},{"pmid":"23201127","id":"PMC_23201127","title":"Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23201127","citation_count":265,"is_preprint":false},{"pmid":"29364506","id":"PMC_29364506","title":"The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms.","date":"2018","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/29364506","citation_count":244,"is_preprint":false},{"pmid":"26437364","id":"PMC_26437364","title":"Regulation of mitochondrial biogenesis through TFAM-mitochondrial DNA interactions: Useful insights from aging and calorie restriction studies.","date":"2015","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/26437364","citation_count":239,"is_preprint":false},{"pmid":"22037171","id":"PMC_22037171","title":"The mitochondrial transcription and packaging factor Tfam imposes a U-turn on mitochondrial DNA.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22037171","citation_count":235,"is_preprint":false},{"pmid":"24435062","id":"PMC_24435062","title":"Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24435062","citation_count":201,"is_preprint":false},{"pmid":"20410300","id":"PMC_20410300","title":"Human mitochondrial transcription revisited: only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20410300","citation_count":162,"is_preprint":false},{"pmid":"37651673","id":"PMC_37651673","title":"Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation.","date":"2023","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/37651673","citation_count":127,"is_preprint":false},{"pmid":"25822152","id":"PMC_25822152","title":"Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25822152","citation_count":123,"is_preprint":false},{"pmid":"33177163","id":"PMC_33177163","title":"ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis.","date":"2020","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/33177163","citation_count":120,"is_preprint":false},{"pmid":"27966783","id":"PMC_27966783","title":"The Role of Exercise and TFAM in Preventing Skeletal Muscle Atrophy.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27966783","citation_count":119,"is_preprint":false},{"pmid":"38783142","id":"PMC_38783142","title":"TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38783142","citation_count":109,"is_preprint":false},{"pmid":"31208524","id":"PMC_31208524","title":"Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway.","date":"2019","source":"International review of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31208524","citation_count":106,"is_preprint":false},{"pmid":"19656489","id":"PMC_19656489","title":"PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19656489","citation_count":103,"is_preprint":false},{"pmid":"27448789","id":"PMC_27448789","title":"Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion.","date":"2016","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27448789","citation_count":95,"is_preprint":false},{"pmid":"27166683","id":"PMC_27166683","title":"Mitochondrial pathways to cardiac recovery: TFAM.","date":"2016","source":"Heart failure reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27166683","citation_count":86,"is_preprint":false},{"pmid":"37030337","id":"PMC_37030337","title":"Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37030337","citation_count":85,"is_preprint":false},{"pmid":"19496804","id":"PMC_19496804","title":"Overexpression of Tfam protects mitochondria against beta-amyloid-induced oxidative damage in SH-SY5Y cells.","date":"2009","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19496804","citation_count":78,"is_preprint":false},{"pmid":"31088855","id":"PMC_31088855","title":"TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle.","date":"2019","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/31088855","citation_count":74,"is_preprint":false},{"pmid":"29897602","id":"PMC_29897602","title":"Acetylation and phosphorylation of human TFAM regulate TFAM-DNA interactions via contrasting mechanisms.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29897602","citation_count":73,"is_preprint":false},{"pmid":"28126676","id":"PMC_28126676","title":"MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28126676","citation_count":72,"is_preprint":false},{"pmid":"21856379","id":"PMC_21856379","title":"Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21856379","citation_count":71,"is_preprint":false},{"pmid":"27903899","id":"PMC_27903899","title":"Human mitochondrial transcription factors TFAM and TFB2M work synergistically in promoter melting during transcription initiation.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27903899","citation_count":69,"is_preprint":false},{"pmid":"25758951","id":"PMC_25758951","title":"Hydrogen Sulfide Maintains Mitochondrial DNA Replication via Demethylation of TFAM.","date":"2015","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25758951","citation_count":68,"is_preprint":false},{"pmid":"26820294","id":"PMC_26820294","title":"Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26820294","citation_count":66,"is_preprint":false},{"pmid":"34462320","id":"PMC_34462320","title":"High levels of TFAM repress mammalian mitochondrial DNA transcription in vivo.","date":"2021","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/34462320","citation_count":65,"is_preprint":false},{"pmid":"28639399","id":"PMC_28639399","title":"TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28639399","citation_count":64,"is_preprint":false},{"pmid":"30226866","id":"PMC_30226866","title":"Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming.","date":"2018","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/30226866","citation_count":63,"is_preprint":false},{"pmid":"24768991","id":"PMC_24768991","title":"ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson's disease.","date":"2014","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/24768991","citation_count":63,"is_preprint":false},{"pmid":"24769106","id":"PMC_24769106","title":"Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia.","date":"2014","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/24769106","citation_count":62,"is_preprint":false},{"pmid":"11668394","id":"PMC_11668394","title":"Downregulation of Tfam and mtDNA copy number during mammalian spermatogenesis.","date":"2001","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11668394","citation_count":58,"is_preprint":false},{"pmid":"35451091","id":"PMC_35451091","title":"TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis.","date":"2022","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/35451091","citation_count":57,"is_preprint":false},{"pmid":"23991223","id":"PMC_23991223","title":"Genome-wide analysis reveals coating of the mitochondrial genome by TFAM.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23991223","citation_count":57,"is_preprint":false},{"pmid":"35750756","id":"PMC_35750756","title":"TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35750756","citation_count":55,"is_preprint":false},{"pmid":"36858460","id":"PMC_36858460","title":"TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36858460","citation_count":52,"is_preprint":false},{"pmid":"36902127","id":"PMC_36902127","title":"Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36902127","citation_count":50,"is_preprint":false},{"pmid":"30242167","id":"PMC_30242167","title":"Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30242167","citation_count":48,"is_preprint":false},{"pmid":"21113058","id":"PMC_21113058","title":"Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/21113058","citation_count":45,"is_preprint":false},{"pmid":"35210991","id":"PMC_35210991","title":"mito-TEMPO Attenuates Oxidative Stress and Mitochondrial Dysfunction in Noise-Induced Hearing Loss via Maintaining TFAM-mtDNA Interaction and Mitochondrial Biogenesis.","date":"2022","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35210991","citation_count":42,"is_preprint":false},{"pmid":"33273525","id":"PMC_33273525","title":"Mitochondrial dysfunction in sepsis is associated with diminished intramitochondrial TFAM despite its increased cellular expression.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33273525","citation_count":40,"is_preprint":false},{"pmid":"32596237","id":"PMC_32596237","title":"Tfam Knockdown Results in Reduction of mtDNA Copy Number, OXPHOS Deficiency and Abnormalities in Zebrafish Embryos.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32596237","citation_count":40,"is_preprint":false},{"pmid":"28433632","id":"PMC_28433632","title":"Role of microRNA-130b in placental PGC-1α/TFAM mitochondrial biogenesis pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28433632","citation_count":39,"is_preprint":false},{"pmid":"31419493","id":"PMC_31419493","title":"Limited predictive value of TFAM in mitochondrial biogenesis.","date":"2019","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/31419493","citation_count":37,"is_preprint":false},{"pmid":"29259235","id":"PMC_29259235","title":"Transcriptomic analysis of mitochondrial TFAM depletion changing cell morphology and proliferation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29259235","citation_count":36,"is_preprint":false},{"pmid":"18636550","id":"PMC_18636550","title":"Expression of mitochondrial transcription factor A (TFAM) during porcine gametogenesis and preimplantation embryo development.","date":"2008","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18636550","citation_count":36,"is_preprint":false},{"pmid":"26166229","id":"PMC_26166229","title":"Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells.","date":"2015","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26166229","citation_count":36,"is_preprint":false},{"pmid":"29872558","id":"PMC_29872558","title":"TFAM is a novel mediator of immunogenic cancer cell death.","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/29872558","citation_count":35,"is_preprint":false},{"pmid":"32971400","id":"PMC_32971400","title":"The interaction between C/EBPβ and TFAM promotes acute kidney injury via regulating NLRP3 inflammasome-mediated pyroptosis.","date":"2020","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32971400","citation_count":35,"is_preprint":false},{"pmid":"30172371","id":"PMC_30172371","title":"Resistin destroys mitochondrial biogenesis by inhibiting the PGC-1α/ NRF1/TFAM signaling pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30172371","citation_count":35,"is_preprint":false},{"pmid":"27469241","id":"PMC_27469241","title":"HIF-1 regulates insect lifespan extension by inhibiting c-Myc-TFAM signaling and mitochondrial biogenesis.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27469241","citation_count":35,"is_preprint":false},{"pmid":"32461017","id":"PMC_32461017","title":"TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32461017","citation_count":34,"is_preprint":false},{"pmid":"26182383","id":"PMC_26182383","title":"The regulation of mitochondrial transcription factor A (Tfam) expression during skeletal muscle cell differentiation.","date":"2015","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/26182383","citation_count":34,"is_preprint":false},{"pmid":"20977898","id":"PMC_20977898","title":"Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese.","date":"2010","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20977898","citation_count":34,"is_preprint":false},{"pmid":"29374989","id":"PMC_29374989","title":"KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM.","date":"2018","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/29374989","citation_count":32,"is_preprint":false},{"pmid":"24462998","id":"PMC_24462998","title":"Upregulation of TFAM and mitochondria copy number in human lymphoblastoid cells.","date":"2014","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/24462998","citation_count":32,"is_preprint":false},{"pmid":"34003544","id":"PMC_34003544","title":"The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.","date":"2021","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34003544","citation_count":31,"is_preprint":false},{"pmid":"35165165","id":"PMC_35165165","title":"TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.","date":"2022","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/35165165","citation_count":30,"is_preprint":false},{"pmid":"33670365","id":"PMC_33670365","title":"Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33670365","citation_count":30,"is_preprint":false},{"pmid":"38087167","id":"PMC_38087167","title":"The Protective Mechanism of TFAM on Mitochondrial DNA and its Role in Neurodegenerative Diseases.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38087167","citation_count":29,"is_preprint":false},{"pmid":"29856906","id":"PMC_29856906","title":"HuR stabilizes TFAM mRNA in an ATM/p38-dependent manner in ionizing irradiated cancer cells.","date":"2018","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/29856906","citation_count":29,"is_preprint":false},{"pmid":"32671959","id":"PMC_32671959","title":"Platelet factor 4 enhances CD4+ T effector memory cell responses via Akt-PGC1α-TFAM signaling-mediated mitochondrial biogenesis.","date":"2020","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/32671959","citation_count":28,"is_preprint":false},{"pmid":"28440425","id":"PMC_28440425","title":"Mitochondrial transcription factor A (TFAM) is upregulated in glioma.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28440425","citation_count":27,"is_preprint":false},{"pmid":"28709643","id":"PMC_28709643","title":"Hypoxia-induced suppression of c-Myc by HIF-2α in human pulmonary endothelial cells attenuates TFAM expression.","date":"2017","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/28709643","citation_count":27,"is_preprint":false},{"pmid":"18430995","id":"PMC_18430995","title":"Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease.","date":"2008","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/18430995","citation_count":26,"is_preprint":false},{"pmid":"32198124","id":"PMC_32198124","title":"The neuroprotective effect of NeuroAid on morphine-induced amnesia with respect to the expression of TFAM, PGC-1α, ΔfosB and CART genes in the hippocampus of male Wistar rats.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32198124","citation_count":26,"is_preprint":false},{"pmid":"25869329","id":"PMC_25869329","title":"Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM).","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25869329","citation_count":26,"is_preprint":false},{"pmid":"38547618","id":"PMC_38547618","title":"Gastrodin alleviates mitochondrial dysfunction by regulating SIRT3-mediated TFAM acetylation in vascular dementia.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38547618","citation_count":25,"is_preprint":false},{"pmid":"37372108","id":"PMC_37372108","title":"35 Years of TFAM Research: Old Protein, New Puzzles.","date":"2023","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37372108","citation_count":25,"is_preprint":false},{"pmid":"29684311","id":"PMC_29684311","title":"TFAM is required for maturation of the fetal and adult intestinal epithelium.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29684311","citation_count":25,"is_preprint":false},{"pmid":"24875355","id":"PMC_24875355","title":"Negative transcriptional regulation of mitochondrial transcription factor A (TFAM) by nuclear TFAM.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24875355","citation_count":24,"is_preprint":false},{"pmid":"36257219","id":"PMC_36257219","title":"Zhen Wu decoction represses renal fibrosis by invigorating tubular NRF2 and TFAM to fuel mitochondrial bioenergetics.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36257219","citation_count":24,"is_preprint":false},{"pmid":"36172183","id":"PMC_36172183","title":"Photobiomodulation promotes repair following spinal cord injury by restoring neuronal mitochondrial bioenergetics via AMPK/PGC-1α/TFAM pathway.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36172183","citation_count":24,"is_preprint":false},{"pmid":"18248889","id":"PMC_18248889","title":"Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18248889","citation_count":24,"is_preprint":false},{"pmid":"21920408","id":"PMC_21920408","title":"The role of TFAM-associated proteins in mitochondrial RNA metabolism.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21920408","citation_count":23,"is_preprint":false},{"pmid":"38241915","id":"PMC_38241915","title":"Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38241915","citation_count":23,"is_preprint":false},{"pmid":"36583367","id":"PMC_36583367","title":"DNA-protein cross-links between abasic DNA damage and mitochondrial transcription factor A (TFAM).","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36583367","citation_count":23,"is_preprint":false},{"pmid":"29902488","id":"PMC_29902488","title":"TGF-β and BMP signals regulate insect diapause through Smad1-POU-TFAM pathway.","date":"2018","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29902488","citation_count":21,"is_preprint":false},{"pmid":"29030253","id":"PMC_29030253","title":"Polymorphisms in the TFAM and PGC1-α genes and their association with polycystic ovary syndrome among South Indian women.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29030253","citation_count":21,"is_preprint":false},{"pmid":"33760663","id":"PMC_33760663","title":"Mitochondrial functional resilience after TFAM ablation in the adult heart.","date":"2021","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33760663","citation_count":19,"is_preprint":false},{"pmid":"36474281","id":"PMC_36474281","title":"GCN5L1-mediated TFAM acetylation at K76 participates in mitochondrial biogenesis in acute kidney injury.","date":"2022","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36474281","citation_count":19,"is_preprint":false},{"pmid":"31137890","id":"PMC_31137890","title":"Differences in Liver TFAM Binding to mtDNA and mtDNA Damage between Aged and Extremely Aged Rats.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31137890","citation_count":18,"is_preprint":false},{"pmid":"31062473","id":"PMC_31062473","title":"Down-regulation of TFAM increases the sensitivity of tumour cells to radiation via p53/TIGAR signalling pathway.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31062473","citation_count":18,"is_preprint":false},{"pmid":"38346661","id":"PMC_38346661","title":"Potential effect of acupuncture on mitochondrial biogenesis, energy metabolism and oxidation stress in MCAO rat via PGC-1α/NRF1/TFAM pathway.","date":"2024","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/38346661","citation_count":18,"is_preprint":false},{"pmid":"17707600","id":"PMC_17707600","title":"Transcription factor hStaf/ZNF143 is required for expression of the human TFAM gene.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17707600","citation_count":18,"is_preprint":false},{"pmid":"37742962","id":"PMC_37742962","title":"Mitochondrial DNA release mediated by TFAM deficiency promotes copper-induced mitochondrial innate immune response via cGAS-STING signalling in chicken hepatocytes.","date":"2023","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/37742962","citation_count":18,"is_preprint":false},{"pmid":"34928349","id":"PMC_34928349","title":"A minimal motif for sequence recognition by mitochondrial transcription factor A (TFAM).","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34928349","citation_count":17,"is_preprint":false},{"pmid":"32342250","id":"PMC_32342250","title":"Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.","date":"2020","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/32342250","citation_count":17,"is_preprint":false},{"pmid":"38593898","id":"PMC_38593898","title":"Polysaccharides from Polygonatum kingianum Collett & Hemsl ameliorated fatigue by regulating NRF2/HO-1/NQO1 and AMPK/PGC-1α/TFAM signaling pathways, and gut microbiota.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38593898","citation_count":17,"is_preprint":false},{"pmid":"28800400","id":"PMC_28800400","title":"Mechanisms of TFAM-mediated cardiomyocyte protection.","date":"2017","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28800400","citation_count":16,"is_preprint":false},{"pmid":"36591497","id":"PMC_36591497","title":"Agrimol B inhibits colon carcinoma progression by blocking mitochondrial function through the PGC-1α/NRF1/TFAM signaling pathway.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36591497","citation_count":16,"is_preprint":false},{"pmid":"28242328","id":"PMC_28242328","title":"Mitochondrial transcription factor A (TFAM) rs1937 and AP endonuclease 1 (APE1) rs1130409 alleles are associated with reduced cognitive performance.","date":"2017","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/28242328","citation_count":16,"is_preprint":false},{"pmid":"30845180","id":"PMC_30845180","title":"Edition of TFAM gene by CRISPR/Cas9 technology in bovine model.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30845180","citation_count":15,"is_preprint":false},{"pmid":"36497015","id":"PMC_36497015","title":"TFAM's Contributions to mtDNA Replication and OXPHOS Biogenesis Are Genetically Separable.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36497015","citation_count":12,"is_preprint":false},{"pmid":"37305705","id":"PMC_37305705","title":"Reduced acetylation of TFAM promotes bioenergetic dysfunction in the failing heart.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37305705","citation_count":12,"is_preprint":false},{"pmid":"38741475","id":"PMC_38741475","title":"Nicorandil mitigates arsenic trioxide-induced lung injury via modulating vital signalling pathways SIRT1/PGC-1α/TFAM, JAK1/STAT3, and miRNA-132 expression.","date":"2024","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38741475","citation_count":12,"is_preprint":false},{"pmid":"34823421","id":"PMC_34823421","title":"Knock out hepatic Krüppel-like factor 16 (KLF16) improve myocardial damage and promoted myocardial protection of myocardial ischemia-reperfusion via anti-oxidative and anti-inflammation effects by TFAM/PPARβ signal passage.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34823421","citation_count":12,"is_preprint":false},{"pmid":"39210159","id":"PMC_39210159","title":"TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells.","date":"2024","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39210159","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48158,"output_tokens":8432,"usd":0.135477},"stage2":{"model":"claude-opus-4-6","input_tokens":12294,"output_tokens":4551,"usd":0.262867},"total_usd":0.398344,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Human mtDNA is packaged with TFAM: TFAM and mtDNA co-immunoprecipitate using anti-TFAM antibodies from human placental mitochondria, TFAM is released by DNase I digestion, and TFAM is abundant enough to coat the entire mtDNA molecule, demonstrating tight physical association of TFAM with mtDNA in vivo.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, DNase I digestion assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional DNase I validation, foundational paper\",\n      \"pmids\": [\"12626705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"X-ray crystal structure of human TFAM bound to mitochondrial LSP promoter DNA reveals that TFAM forces DNA to undergo a U-turn, with each HMG-box domain wedging into the DNA minor groove to generate two kinks on one face, and a positively charged α-helix on the opposite face serving as a bending platform.\",\n      \"method\": \"X-ray crystallography with functional mutagenesis\",\n      \"journal\": \"Nature Structural & Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mechanistic validation of DNA bending\",\n      \"pmids\": [\"22037171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structures of TFAM bound to HSP1 and non-specific DNA show TFAM imposes a U-turn in both contexts but binds HSP1 in the opposite orientation from LSP, explaining promoter-specific transcriptional requirements. TFAM dimerizes when DNA-bound; dimerization is dispensable for DNA bending and transcriptional activation but important for DNA compaction and looping.\",\n      \"method\": \"X-ray crystallography, in vitro transcription assay, dimerization mutagenesis\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple crystal structures with mutagenesis and functional assays in one study\",\n      \"pmids\": [\"24435062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Superresolution and electron microscopy showed that the mitochondrial nucleoid contains a single copy of mtDNA, and rotary-shadowing EM revealed that nucleoid formation in vitro is initiated by TFAM aggregation and cross-strand binding, establishing the fundamental organizational unit of the nucleoid.\",\n      \"method\": \"Superresolution microscopy (STED), electron cryo-tomography, rotary shadowing EM, biochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal structural/imaging methods with in vitro reconstitution\",\n      \"pmids\": [\"26305956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Reconstituted in vitro transcription demonstrates that only TFAM and TFB2M (not TFB1M) are required to drive transcription from LSP and HSP1, acting synergistically to increase transcription 100–200-fold over RNA polymerase alone, with maximal activity when TFAM is equimolar to the DNA template.\",\n      \"method\": \"Reconstituted in vitro transcription with recombinant proteins\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — fully reconstituted in vitro system with systematic factor omission\",\n      \"pmids\": [\"20410300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"2-aminopurine fluorescence mapping of promoter melting shows TFAM has post-recruitment roles in LSP promoter melting and stabilization of the open complex; POLRMT requires both TFB2M and TFAM to efficiently melt the promoter, and TFAM is necessary for synthesis of abortive RNAs longer than 2-mer.\",\n      \"method\": \"2-aminopurine fluorescence assay, equilibrium binding assay, abortive RNA synthesis assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro biochemical methods in a single study reconstituting transcription initiation steps\",\n      \"pmids\": [\"27903899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TFAM is phosphorylated within HMG box 1 (HMG1) by cAMP-dependent protein kinase inside mitochondria; HMG1 phosphorylation impairs TFAM DNA binding and transcriptional activation. Only DNA-free TFAM is degraded by the Lon protease; in cells with normal mtDNA levels, phosphorylated TFAM is selectively degraded by Lon.\",\n      \"method\": \"Mass spectrometry phosphorylation mapping, in vitro kinase assay, in vitro transcription, Lon protease degradation assay, siRNA knockdown\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay, in vitro transcription, and protease assay with mutagenesis, replicated across cell conditions\",\n      \"pmids\": [\"23201127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ERK1/2 directly phosphorylates TFAM at serine 177; phosphomimetic mutation at S177 recapitulates the effect of MPP+ in decreasing TFAM binding to the LSP and suppressing mitochondrial transcription, and mutant TFAM fails to rescue respiratory function.\",\n      \"method\": \"Mass spectrometry phosphosite identification, site-directed mutagenesis, TFAM-DNA binding assay, mitochondrial transcription assay\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — MS identification combined with mutagenesis and functional transcription/binding assays\",\n      \"pmids\": [\"24768991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TFAM is lysine-acetylated within HMG box 1; acetyl-lysine and phosphoserine mimics both reduce TFAM DNA compaction capacity but through distinct kinetic mechanisms: the acetyl-lysine mimic shows a lower on-rate, whereas the phosphoserine mimic shows both decreased on-rate and increased off-rate with faster diffusion of TFAM along DNA.\",\n      \"method\": \"Single-molecule fluorescence assay, bulk binding assay, site-directed mutagenesis with PTM mimics\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule and ensemble methods with mutagenesis in one study\",\n      \"pmids\": [\"29897602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The TFAM-to-mtDNA ratio (not absolute TFAM level) determines mtDNA expression; very high TFAM levels in mouse skeletal muscle repress mtDNA transcription, while in liver elevated LONP1 protease and mtRNA polymerase counteract TFAM-mediated silencing, establishing TFAM as a general repressor of mtDNA expression.\",\n      \"method\": \"Transgenic mouse overexpression, tissue-specific analysis, OXPHOS functional assays\",\n      \"journal\": \"Life Science Alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with tissue-specific mechanistic dissection\",\n      \"pmids\": [\"34462320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ChIP-seq in human cells demonstrates that TFAM uniformly coats the entire mitochondrial genome without preferred binding sites (beyond promoter regions) and shows no robust binding to the nuclear genome, establishing genome-wide non-specific mtDNA packaging by TFAM.\",\n      \"method\": \"ChIP-seq\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide direct binding assay in human cells\",\n      \"pmids\": [\"23991223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PDX1 directly regulates TFAM as a transcriptional target in beta cells; adenoviral overexpression of TFAM in PDX1-dominant-negative islets rescues mtDNA copy number, respiratory chain activity, ATP synthesis, and glucose-stimulated insulin secretion.\",\n      \"method\": \"Transcript profiling, promoter binding assay, adenoviral overexpression, respiratory chain activity assay, insulin secretion assay\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter occupancy and functional rescue with multiple orthogonal readouts\",\n      \"pmids\": [\"19656489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TFAM acts as an autophagy receptor (nucleoid-phagy) for cytoplasmic mtDNA via a LIR (LC3-interacting region) motif that enables direct binding to LC3 on autolysosomes; mutating the LIR motif increases cytoplasmic mtDNA accumulation and activates inflammatory signaling without affecting TFAM's mitochondrial functions.\",\n      \"method\": \"LIR motif mutagenesis, co-immunoprecipitation with LC3, live-cell autolysosome imaging, inflammatory pathway readout\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of functional motif with mechanistic imaging and signaling readout in one study\",\n      \"pmids\": [\"38783142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TFAM deficiency blocks the TCA cycle and increases intracellular malonyl-CoA, leading to malonylation of the actin nucleator mDia2, which promotes mDia2 nuclear translocation and polymerization of nuclear actin, thereby altering chromatin accessibility and upregulating metastasis-associated gene programs in liver cancer.\",\n      \"method\": \"Metabolomics, malonylation proteomics, nuclear actin imaging, chromatin accessibility assay, in vivo metastasis model\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing a novel retrograde signaling pathway\",\n      \"pmids\": [\"35451091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TFAM and TFB2M localize to the nucleus in rat neonatal cardiomyocytes and directly bind the Serca2 gene promoter (at −122 to −114 nt and −122 to −117 nt regions respectively) as shown by ChIP and fluorescence correlation spectroscopy; mutation of these sites decreases Serca2 transcription.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), fluorescence correlation spectroscopy, promoter mutation/reporter assay, immunostaining\",\n      \"journal\": \"Cardiovascular Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and FCS in a single lab, nuclear localization confirmed but nuclear role is non-canonical\",\n      \"pmids\": [\"21113058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nuclear TFAM suppresses its own gene expression by interacting with NRF-1 and acting as an NRF-1 repressor; TFAM co-immunoprecipitates with NRF-1, and mitochondria targeting sequence-deficient TFAM represses the Tfam promoter to the same degree, indicating this autoregulatory role is nuclear and independent of mitochondrial function.\",\n      \"method\": \"Immunostaining, subcellular fractionation, GFP fusion localization, co-immunoprecipitation, luciferase promoter assay\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP and reporter assay in a single lab; nuclear role is non-canonical but mechanistically supported\",\n      \"pmids\": [\"24875355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"H2S (via the CSE/H2S system) maintains TFAM expression and mtDNA copy number by S-sulfhydrating the transcriptional repressor IRF-1, enhancing its binding to the Dnmt3a promoter and reducing Dnmt3a expression, thereby preventing TFAM promoter methylation.\",\n      \"method\": \"S-sulfhydration assay, ChIP, bisulfite sequencing/methylation assay, siRNA knockdown, qPCR\",\n      \"journal\": \"Antioxidants & Redox Signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods in single lab linking H2S to TFAM epigenetic regulation\",\n      \"pmids\": [\"25758951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In kidney fibrosis, Notch2 signaling (activated by Jagged1) directly represses Tfam transcription as identified by chromatin immunoprecipitation; re-expression of Tfam in tubule cells prevents Notch-induced metabolic and profibrotic reprogramming, and tubule-specific Tfam deletion itself causes fibrosis.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), genome-wide expression profiling, conditional knockout mice, adenoviral re-expression\",\n      \"journal\": \"PLoS Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus in vivo genetic epistasis with rescue experiment\",\n      \"pmids\": [\"30226866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"mtROS promotes Lon protease-mediated TFAM degradation and suppresses TFAM transcription, reducing mtDNA copy number; silencing TFAM abolishes the rescue of mitochondrial function and cytokine release by the mtROS inhibitor Mito-Tempo, placing TFAM downstream of mtROS in kidney injury.\",\n      \"method\": \"Lon protease functional assay, TFAM knockdown (siRNA), mitochondrial respiration assay, cytokine measurement, Mito-Tempo pharmacological inhibition\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via TFAM silencing with multiple functional readouts in one lab\",\n      \"pmids\": [\"33408785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In sepsis, ATF4 represses TFAM by binding to and inhibiting the transcriptional activity of NRF1 (a key TFAM activator) at its promoter; hepatocyte-specific TFAM overexpression rescues alcohol-induced mitochondrial dysfunction and liver damage in mice.\",\n      \"method\": \"ATF4 knockout mice, TFAM overexpression mice, promoter binding assay (ChIP/luciferase), mitochondrial biogenesis/respiration assays\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic models combined with direct promoter binding, replicated in cells and mice\",\n      \"pmids\": [\"33177163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GCN5L1 acetyltransferase acetylates TFAM at lysine 76 (K76), which inhibits TFAM binding to the mitochondrial import receptor TOM70, thereby reducing TFAM import into mitochondria and mitochondrial biogenesis in acute kidney injury.\",\n      \"method\": \"Acetylated proteomics, proximity ligation assay, co-immunoprecipitation, GCN5L1 knockdown, mtDNA copy number assay\",\n      \"journal\": \"Journal of Translational Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — acetylome proteomics identifying specific site, confirmed by PLA and co-IP with functional import assay\",\n      \"pmids\": [\"36474281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIRT3 deacetylates TFAM at K5, K7, and K8 residues as demonstrated by immunoprecipitation and mass spectrometry; decreased SIRT3 leads to hyper-acetylated TFAM, impaired mitochondrial function, and vascular dementia pathology.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, SIRT3 inhibitor/knockdown, mitochondrial function assays\",\n      \"journal\": \"Phytomedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IP-MS identifying specific acetylation sites with functional correlates in single lab\",\n      \"pmids\": [\"38547618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Extracellular TFAM acts as a DAMP recognized by human microglia: recombinant human TFAM induces secretion of IL-1β, IL-6, and IL-8 from THP-1 monocytic cells and, with IFN-γ, elicits cytotoxic secretions from microglia and monocytes through a mechanism partially dependent on JNK activation.\",\n      \"method\": \"Recombinant protein treatment of primary human microglia and THP-1 cells, cytokine ELISA, neurotoxicity assay, specific kinase inhibitors\",\n      \"journal\": \"Molecular and Cellular Neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — recombinant protein functional assay in multiple human cell types with inhibitor validation\",\n      \"pmids\": [\"24769106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Release of TFAM from apoptotic cancer cells acts as a mitochondrial DAMP that contributes to immunogenic cell death via the receptor AGER; neutralizing antibodies to TFAM or AGER abolish the immunogenic effect of spautin-1-treated cancer cells in vivo.\",\n      \"method\": \"Neutralizing antibody blockade, in vivo tumor inoculation, in vitro apoptosis assay\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific antibody blockade in vivo with functional readout\",\n      \"pmids\": [\"29872558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Crystal structure of TFAM bound to non-sequence-specific DNA containing a GN10G motif reveals that TFAM bridges two DNA substrates via two guanine-specific interactions; mutagenesis and biochemical assays show the GN10G consensus is essential for transcription initiation and contributes to general DNA binding.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, in vitro transcription assay, DNA binding assay\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and functional assays\",\n      \"pmids\": [\"34928349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TFAM forms DNA-protein cross-links (DPCs) with abasic (AP) sites in mtDNA: TFAM cleaves AP-DNA, generating a 3'-phospho-α,β-unsaturated aldehyde (3'pUA) that reacts with Cys residues of TFAM to form stable DPCs, with Lys residues critical for initial AP-DNA cleavage; glutathione competes with TFAM-DPC formation.\",\n      \"method\": \"In vitro DPC formation assay, mass spectrometry, mutagenesis of Lys/Cys residues, cellular DPC assay with glutathione modulation\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and cellulo mechanistic assays with mutagenesis identifying reactive residues\",\n      \"pmids\": [\"36583367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"During mammalian spermatogenesis, mitochondrial TFAM protein levels are progressively downregulated coincident with downregulation of mtDNA copy number, establishing a direct in vivo correlation between mitochondrial TFAM abundance and mtDNA copy number control during differentiation.\",\n      \"method\": \"Immunoblotting with subcellular fractionation, mtDNA quantification across spermatogenic stages in rat, mouse, and human\",\n      \"journal\": \"Mammalian Genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein measurement across developmental stages, conserved across three mammalian species\",\n      \"pmids\": [\"11668394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TFAM-deficient alveolar macrophages (AMs) show diminished proliferation/self-renewal gene programs and increased inflammatory gene expression; conditional TFAM knockout in mice reduces AM numbers and impairs AM maturation without affecting AM precursor generation or initial differentiation, establishing TFAM-mediated mitochondrial metabolism as specifically required for AM compartment maintenance.\",\n      \"method\": \"Conditional knockout mice, transcriptional profiling, flow cytometry, in vivo influenza infection model\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific in vivo genetic knockout with transcriptomics and functional immune readouts\",\n      \"pmids\": [\"35165165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TFAM deficiency in dendritic cells causes mitochondrial dysfunction and cytosolic mtDNA leakage that activates the cGAS-STING pathway, enhancing antigen presentation and reversing immunosuppressive tumor microenvironment; STING inhibitors abrogate this effect, placing TFAM upstream of cGAS-STING in DC immune activation.\",\n      \"method\": \"Conditional knockout mice, primary BMDC functional assays, STING inhibitor, tumor models, antigen presentation assay\",\n      \"journal\": \"Journal for Immunotherapy of Cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with pharmacological epistasis and in vivo tumor model\",\n      \"pmids\": [\"36858460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"KLF16 transcription factor directly suppresses glioma cell proliferation by binding a site near the TFAM transcription start site and repressing TFAM expression, as validated by luciferase assay and chromatin immunoprecipitation.\",\n      \"method\": \"Luciferase reporter assay, chromatin immunoprecipitation (ChIP), KLF16 overexpression/siRNA, in vivo xenograft\",\n      \"journal\": \"Artificial Cells, Nanomedicine, and Biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP and reporter assay in single lab for transcriptional regulation\",\n      \"pmids\": [\"29374989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The transcription factor hStaf/ZNF143 is required for normal human TFAM gene expression: two conserved hStaf/ZNF143 binding sites in the TFAM promoter are identified by promoter binding assays and ChIP, and mutation of these sites reduces TFAM promoter activity.\",\n      \"method\": \"Promoter binding assay, transient transfection with mutant reporter constructs, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and promoter mutagenesis in a single lab\",\n      \"pmids\": [\"17707600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genetic analysis using chimeric TFAM variants (GeneSwap approach) shows that TFAM's contributions to mtDNA replication and respiratory chain biogenesis are genetically separable: variant Ch13 has low mtDNA copy number but robust respiration, while Ch22 has the converse; residues making DNA contacts are primarily responsible for mtDNA replication.\",\n      \"method\": \"Chimeric protein engineering (GeneSwap), mtDNA copy number assay, respiratory function assay, mutagenesis\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — structure-guided mutagenesis with two complementary functional readouts, single lab\",\n      \"pmids\": [\"36497015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GCN5L1 loss reduces TFAM acetylation, which is linked to decreased mtDNA levels and impaired mitochondrial bioenergetics under hemodynamic stress in the heart; GCN5L1 cardiomyocyte-specific knockout mice show exacerbated heart failure after transaortic constriction.\",\n      \"method\": \"Cardiomyocyte-specific GCN5L1 knockout mice, TAC model, TFAM acetylation assay, mtDNA quantification, bioenergetics assay\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional knockout with acetylation assay and functional mitochondrial readouts\",\n      \"pmids\": [\"37305705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TFAM knockdown in gastric cancer cells activates mtDNA depletion-dependent calcium-mediated retrograde signaling through the CFAP65-PCK1 axis; knockdown of CFAP65 or PCK1 rescues cell morphology and proliferation changes caused by TFAM depletion, and mtDNA depletion by ddC is sufficient to induce CFAP65 and PCK1 upregulation.\",\n      \"method\": \"TFAM siRNA knockdown, mtDNA depletion by ddC, gene-specific knockdown rescue, transcriptomic analysis\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via rescue experiment placing CFAP65-PCK1 downstream of TFAM-mtDNA in retrograde signaling\",\n      \"pmids\": [\"29259235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIRT3 deacetylates TFAM, and sepsis-induced AKI is associated with melatonin promoting SIRT3-mediated TFAM deacetylation to promote mitophagy.\",\n      \"method\": \"In vivo sepsis model, SIRT3 activity assay, mitophagy assay (mKeima), TFAM acetylation measurement\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — abstract does not report direct mechanistic deacetylation assay details for TFAM\",\n      \"pmids\": [\"37651673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RNA-binding protein HuR binds and stabilizes TFAM mRNA in irradiated cancer cells; radiation-activated ATM/p38 signaling promotes nuclear-to-cytosol translocation of HuR, enhancing its binding to TFAM mRNA without affecting TFAM transcription or mRNA intrinsic stability.\",\n      \"method\": \"RNA immunoprecipitation (RIP), HuR knockdown, subcellular fractionation of HuR, ATM/p38 inhibitors, mRNA stability assay\",\n      \"journal\": \"Cancer Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RIP demonstrating direct HuR-TFAM mRNA interaction with pathway inhibitor validation\",\n      \"pmids\": [\"29856906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ERAL1 (an ERA-like G-protein) and p32 are identified as TFAM-associated proteins within the mitochondrial nucleoid involved in RNA metabolism: ERAL1 binds mitochondrial 12S rRNA and is an important constituent of the mitochondrial small ribosomal subunit.\",\n      \"method\": \"Co-immunoprecipitation/pulldown to identify TFAM interactors, rRNA binding assay\",\n      \"journal\": \"Biochimica et Biophysica Acta\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — pulldown-based identification of interactors, limited functional follow-up for TFAM itself\",\n      \"pmids\": [\"21920408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TFAM loss in intestinal epithelium (Shh-Cre conditional knockout) impairs villus elongation and enterocyte maturation during fetal development, and in adult intestinal epithelium reduces stem cell renewal and organoid formation while preserving transit-amplifying zone proliferation.\",\n      \"method\": \"Conditional knockout mice (Shh-Cre and inducible adult deletion), molecular profiling, intestinal organoid formation assay\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic knockout with distinct stage-specific phenotypic readouts and organoid assay\",\n      \"pmids\": [\"29684311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Conditional Tfam ablation in adult mouse cardiomyocytes reveals functional resilience: mtDNA content, mitochondrial function, and cardiac function are preserved despite decreased transcript abundance during the acute phase, whereas long-term inactivation downregulates the core mtDNA transcription/replication machinery and causes cardiomyopathy.\",\n      \"method\": \"Conditional knockout mice, mtDNA quantification, mitochondrial function assays, cardiac function assays over time\",\n      \"journal\": \"American Journal of Physiology - Cell Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional in vivo genetic model with longitudinal functional analysis\",\n      \"pmids\": [\"33760663\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TFAM is a dual-function HMG-box protein that (1) activates mitochondrial transcription initiation by bending promoter DNA into a U-turn and working synergistically with TFB2M and POLRMT to melt the promoter, and (2) packages the entire mitochondrial genome into single-copy nucleoids through cross-strand binding and dimerization; its activity is fine-tuned by cAMP-dependent protein kinase (HMG1 phosphorylation at S177 via ERK, or PKA) and acetyltransferase GCN5L1 (K76) / deacetylase SIRT3 (K5/7/8), with phosphorylated/acetylated DNA-free TFAM selectively degraded by the Lon protease, while cytoplasmic mtDNA released upon TFAM loss activates cGAS-STING inflammatory signaling that TFAM itself limits by acting as an autophagy receptor for nucleoid-phagy via its LIR motif.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TFAM is a dual-function HMG-box protein that serves as both the principal architectural packager of the mitochondrial genome and an essential activator of mitochondrial transcription. Structurally, TFAM bends promoter DNA into a U-turn via two HMG-box domains that wedge into the minor groove, and it cooperates with TFB2M and POLRMT to melt the promoter and initiate transcription; at higher stoichiometries, TFAM coats the entire mtDNA through non-sequence-specific binding, cross-strand bridging, and dimerization to compact it into single-copy nucleoids, with the TFAM-to-mtDNA ratio determining whether expression is activated or repressed [PMID:22037171, PMID:24435062, PMID:20410300, PMID:26305956, PMID:34462320]. TFAM activity is fine-tuned by phosphorylation (cAMP-dependent kinase, ERK1/2 at S177) and acetylation (GCN5L1 at K76; SIRT3 at K5/K7/K8), which reduce DNA binding and compaction through distinct kinetic mechanisms; DNA-free phosphorylated or acetylated TFAM is selectively degraded by the Lon protease, coupling post-translational modification to mtDNA copy-number homeostasis [PMID:23201127, PMID:24768991, PMID:29897602, PMID:36474281, PMID:38547618]. Beyond its canonical mitochondrial roles, TFAM functions as an autophagy receptor for cytoplasmic mtDNA via a LIR motif that binds LC3, limiting cGAS–STING inflammatory signaling triggered by escaped mtDNA, and when released extracellularly acts as a DAMP recognized through the receptor AGER [PMID:38783142, PMID:36858460, PMID:29872558].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"An in vivo correlation between TFAM protein abundance and mtDNA copy number was established across mammalian spermatogenesis, raising the question of whether TFAM directly maintains mtDNA levels.\",\n      \"evidence\": \"Immunoblotting and mtDNA quantification across spermatogenic stages in rat, mouse, and human\",\n      \"pmids\": [\"11668394\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative; no genetic manipulation to test causality\", \"Mechanism of TFAM downregulation during spermatogenesis unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The physical association of TFAM with mtDNA in vivo was demonstrated, establishing that TFAM is an abundant nucleoid component rather than merely a transient transcription factor.\",\n      \"evidence\": \"Co-immunoprecipitation from human placental mitochondria with DNase I release validation\",\n      \"pmids\": [\"12626705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry was estimated but not precisely determined\", \"Whether TFAM binding is uniform or site-specific was unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Reconstitution of minimal mitochondrial transcription demonstrated that TFAM and TFB2M (but not TFB1M) are the essential co-activators of POLRMT, defining the core transcription initiation machinery.\",\n      \"evidence\": \"Fully reconstituted in vitro transcription with systematic factor omission\",\n      \"pmids\": [\"20410300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TFAM mechanistically contributes beyond recruitment was not resolved\", \"Structural basis of promoter recognition was still unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The crystal structure of TFAM on LSP revealed that TFAM bends promoter DNA into a U-turn through two HMG-box insertions, providing the first atomic-resolution mechanism for how TFAM remodels DNA for transcription.\",\n      \"evidence\": \"X-ray crystallography of human TFAM–LSP complex with functional mutagenesis\",\n      \"pmids\": [\"22037171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure on HSP1 and non-specific DNA was not yet available\", \"Role of DNA bending in compaction versus transcription was unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that cAMP-dependent kinase phosphorylates TFAM within HMG1, impairing DNA binding and rendering TFAM susceptible to Lon protease degradation, established the first post-translational mechanism coupling signaling to mtDNA copy-number control.\",\n      \"evidence\": \"Mass spectrometry phosphomapping, in vitro kinase and Lon degradation assays, siRNA knockdown\",\n      \"pmids\": [\"23201127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo kinase identity in mitochondria was debated\", \"Whether acetylation similarly regulated Lon degradation was unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"ChIP-seq revealed that TFAM uniformly coats the entire mitochondrial genome without preferred non-promoter binding sites, confirming its role as a general mtDNA packaging factor.\",\n      \"evidence\": \"Genome-wide ChIP-seq in human cells\",\n      \"pmids\": [\"23991223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Resolution limited by nucleoid compaction\", \"Whether coating density varies with physiological state was untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystal structures of TFAM on HSP1 and non-specific DNA showed that TFAM imposes a U-turn regardless of sequence but binds the two promoters in opposite orientations; dimerization was shown to be required for DNA compaction but dispensable for transcription activation, separating the two functions structurally.\",\n      \"evidence\": \"X-ray crystallography, in vitro transcription, dimerization mutagenesis\",\n      \"pmids\": [\"24435062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How dimerization leads to higher-order compaction at the nucleoid scale was not resolved\", \"In vivo validation of dimerization mutants was lacking\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"ERK1/2 was identified as a second kinase phosphorylating TFAM at S177, linking mitochondrial toxin (MPP+) signaling to reduced TFAM–DNA binding and transcriptional suppression.\",\n      \"evidence\": \"Mass spectrometry, phosphomimetic mutagenesis, TFAM-DNA binding and transcription assays\",\n      \"pmids\": [\"24768991\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ERK1/2 accesses mitochondrial TFAM was not fully established\", \"Interplay between PKA and ERK phosphorylation sites was not studied\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Super-resolution and electron microscopy established that each nucleoid contains a single mtDNA copy, and TFAM cross-strand binding and aggregation initiate nucleoid compaction, defining the fundamental unit of mtDNA organization.\",\n      \"evidence\": \"STED microscopy, cryo-ET, rotary shadowing EM, in vitro reconstitution\",\n      \"pmids\": [\"26305956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full 3D architecture of the nucleoid in situ was not achieved\", \"Contribution of other nucleoid proteins to compaction was not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Fluorescence-based promoter melting assays revealed that TFAM has post-recruitment roles in open complex formation, working with TFB2M to melt LSP DNA and enable productive RNA synthesis beyond 2-mer abortive transcripts.\",\n      \"evidence\": \"2-aminopurine fluorescence, equilibrium binding, and abortive RNA synthesis assays\",\n      \"pmids\": [\"27903899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural intermediates of the open complex were not visualized\", \"Whether TFAM participates in promoter escape was unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Single-molecule studies demonstrated that acetylation and phosphorylation of TFAM reduce DNA compaction through kinetically distinct mechanisms—acetylation lowering the on-rate and phosphorylation increasing the off-rate—explaining how different modifications yield different functional outcomes.\",\n      \"evidence\": \"Single-molecule fluorescence, bulk binding, PTM-mimic mutagenesis\",\n      \"pmids\": [\"29897602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological acetylation sites responsible were not mapped in this study\", \"Combined effects of multiple simultaneous PTMs were not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Tissue-specific conditional knockout of TFAM in kidney tubules caused fibrosis, and Notch2 was shown to directly repress Tfam transcription, establishing TFAM as a downstream effector whose loss mediates Notch-driven metabolic reprogramming.\",\n      \"evidence\": \"ChIP for Notch2 on Tfam promoter, conditional Tfam knockout mice, adenoviral Tfam rescue\",\n      \"pmids\": [\"30226866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other developmental pathways similarly regulate Tfam transcription was untested\", \"Mechanism linking TFAM loss to profibrotic gene programs was incompletely defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"In vivo TFAM overexpression in mice demonstrated that the TFAM-to-mtDNA ratio—not absolute TFAM level—determines transcriptional output, with excess TFAM silencing mtDNA expression in skeletal muscle, resolving a long-standing paradox about TFAM's dual activator/repressor behavior.\",\n      \"evidence\": \"Transgenic TFAM-overexpressing mice with tissue-specific OXPHOS and transcription analysis\",\n      \"pmids\": [\"34462320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cells sense and regulate the ratio was not determined\", \"Whether the ratio model applies to all tissues equally was not fully tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"GCN5L1 was identified as the acetyltransferase that acetylates TFAM at K76, inhibiting its binding to the TOM70 import receptor and thereby reducing mitochondrial TFAM import, revealing a new layer of TFAM regulation at the protein import step.\",\n      \"evidence\": \"Acetylome proteomics, proximity ligation assay, co-IP, GCN5L1 knockdown with mtDNA readout\",\n      \"pmids\": [\"36474281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether K76 acetylation also affects DNA binding inside mitochondria was not tested\", \"In vivo GCN5L1–TFAM epistasis was limited to kidney injury context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A crystal structure of TFAM on non-specific DNA revealed a GN10G guanine-specific recognition motif that bridges two DNA substrates, explaining how TFAM achieves both sequence-specific promoter recognition and genome-wide non-specific packaging.\",\n      \"evidence\": \"X-ray crystallography, site-directed mutagenesis, in vitro transcription and binding assays\",\n      \"pmids\": [\"34928349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of GN10G to nucleoid architecture in vivo was not tested\", \"Whether GN10G frequency in mtDNA influences regional compaction is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Chimeric TFAM variants demonstrated that TFAM's contributions to mtDNA replication and respiratory chain biogenesis are genetically separable, with DNA-contacting residues primarily driving replication.\",\n      \"evidence\": \"GeneSwap chimeric protein engineering with mtDNA copy number and respiration assays\",\n      \"pmids\": [\"36497015\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for the separation of function was not determined\", \"Only tested in cell culture, not in vivo\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"TFAM was shown to form covalent DNA-protein crosslinks at abasic sites via a lyase-like activity, with Lys residues cleaving AP-DNA to generate a reactive aldehyde trapped by Cys residues, establishing TFAM as a participant in mtDNA damage responses.\",\n      \"evidence\": \"In vitro DPC formation assay, mass spectrometry of crosslinked species, Lys/Cys mutagenesis, cellular DPC assay\",\n      \"pmids\": [\"36583367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biological consequence of TFAM-DPC accumulation for mtDNA maintenance is unknown\", \"Whether DPCs are resolved by specific repair pathways was not addressed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"SIRT3 was identified as the deacetylase acting on TFAM at K5, K7, and K8, placing TFAM acetylation under mitochondrial sirtuin control and linking SIRT3 decline to TFAM hyper-acetylation and mitochondrial dysfunction.\",\n      \"evidence\": \"IP-MS identifying acetylation sites, SIRT3 knockdown/inhibitor, mitochondrial function assays\",\n      \"pmids\": [\"38547618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in vitro deacetylation assay with purified SIRT3 on specific TFAM peptides was not shown\", \"Interplay between GCN5L1 acetylation at K76 and SIRT3 deacetylation at N-terminal lysines was not studied\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"TFAM loss in dendritic cells was shown to trigger cytosolic mtDNA release and cGAS–STING activation, enhancing antigen presentation and anti-tumor immunity, establishing TFAM as a gatekeeper preventing innate immune activation by mitochondrial DNA.\",\n      \"evidence\": \"Conditional Tfam knockout in DCs, STING pharmacological inhibition, tumor models, antigen presentation assays\",\n      \"pmids\": [\"36858460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the effect is specific to dendritic cells or general to all antigen-presenting cells was not established\", \"Direct visualization of mtDNA escape from mitochondria was limited\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"TFAM was discovered to function as an autophagy receptor for cytoplasmic mtDNA through a LIR motif that binds LC3, defining a nucleoid-phagy pathway that clears escaped mtDNA and suppresses cGAS–STING signaling independently of TFAM's intramitochondrial roles.\",\n      \"evidence\": \"LIR motif mutagenesis, co-IP with LC3, live-cell autolysosome imaging, inflammatory pathway readout\",\n      \"pmids\": [\"38783142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether nucleoid-phagy operates in all cell types is unknown\", \"Regulation of TFAM's LIR motif accessibility was not addressed\", \"How cytoplasmic TFAM is distinguished from mitochondrial TFAM for this function is unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Outstanding questions include: (1) the full 3D structure of the TFAM-organized nucleoid in situ; (2) how the combined landscape of phosphorylation, acetylation, and DPC formation is integrated to control TFAM's partition between transcription activation, genome packaging, and degradation; and (3) the structural and regulatory basis for TFAM's cytoplasmic autophagy receptor function versus its mitochondrial roles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in situ structure of the complete nucleoid exists\", \"Combinatorial PTM effects on TFAM have not been reconstituted\", \"Mechanism governing TFAM cytoplasmic pool availability for nucleoid-phagy is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 10, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [3, 2, 10]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 3, 10, 37, 38]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 3, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [4, 5, 9]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [3, 26, 31]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28, 22, 23]}\n    ],\n    \"complexes\": [\n      \"mitochondrial nucleoid\",\n      \"mitochondrial transcription initiation complex (TFAM–TFB2M–POLRMT)\"\n    ],\n    \"partners\": [\n      \"TFB2M\",\n      \"POLRMT\",\n      \"LONP1\",\n      \"GCN5L1\",\n      \"SIRT3\",\n      \"TOMM70\",\n      \"AGER\",\n      \"MAP1LC3B\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}